Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential

Huizhou Fan, Cristy Villegas, Jim A. Wright

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Fingerprint Dive into the research topics of 'Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential'. Together they form a unique fingerprint.

Medicine & Life Sciences